Apogee Therapeutics Inc.

33.11
1.07 (3.34%)
At close: Apr 17, 2025, 3:59 PM
32.47
-1.93%
After-hours: Apr 17, 2025, 05:11 PM EDT

Apogee Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
-182.15M -146.66M -118.48M -103.55M -83.98M -66.26M -65.07M -46.19M -33.67M -19.66M -6.12K -4.3K
189K 113K 65K 29K n/a n/a n/a n/a n/a n/a n/a n/a
23.33M 17.93M 13.6M 9.02M 6.1M 6.03M 4.53M 3.42M 2.14M n/a n/a n/a
-4.88M 1.41M 7.78M 803K 4.49M 4.74M -1.48M 5.18M 4.97M 3.24M 3.32K 1.72K
-4.51M -5.04M -6.1M -3.33M -2.97M 341.34K 9.72M 9.71M 9.72M 9.15M 2.8K 2.58K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-5.96M 2.52M 2.44M 4.1M 6.11M 5.7M 9.28M 6.08M 5.39M 3.27M 3.32K 1.72K
-171.17M -133.21M -110.57M -95.84M -74.76M -54.2M -41.55M -26.98M -16.43M -7.24M n/a n/a
-1.15M -1.32M -569K -518K -167K n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-649.45M -658.39M -656.6M -429.63M -303.74M -234.22M n/a n/a n/a n/a n/a n/a
350.14M 273.19M 182.81M 104.5M 30M n/a n/a n/a n/a n/a n/a n/a
-51.39K -234.27M -51.39K -51.39K n/a 234.22M n/a n/a n/a n/a n/a n/a
-300.46M -620.74M -708.58M -559.87M -508.13M -234.22M n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
1.24M 407K 1.72M 24K n/a 173.8K 3.33M 5.02M 5.03M 4.85M 4.97K 5K
495.11M 450.54M 767.46M 765.91M 315.39M 315.78M 3.33M 5.02M 5.03M 4.85M 4.97K 5K
23.47M -69.49M 182.23M 344.12M -33.57M 185.69M 122.48M 138.75M 149.31M 2.58K 4.97K 5K
-172.33M -134.53M -111.14M -96.36M -74.93M -54.2M -41.55M -26.98M -16.43M -7.24M n/a n/a